The mouse light/dark box test

被引:971
作者
Bourin, M [1 ]
Hascoët, M [1 ]
机构
[1] Fac Med, EA 3256, F-44035 Nantes 1, France
关键词
antidepressant; antipsychotic; anxiolytic; light/dark test; mouse; neuropeptide receptor ligand;
D O I
10.1016/S0014-2999(03)01274-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The light/dark test is based on the innate aversion of rodents to brightly illuminated areas and on the spontaneous exploratory behaviour of rodents in response to mild stressors, that is, novel environment and light. The test apparatus consists of a small dark safe compartment (one third) and a large illuminated aversive compartment (two thirds). The test was developed with male mice. The strain, weight and age may be crucial factors. The extent to which an anxiolytic compound can facilitate exploratory activity depends on the baseline level in the control group. Differences between the type and severity of external stressors might account for the variable results reported by different laboratories. The light/dark test may be useful to predict anxiolytic-like or anxiogenic-like activity in mice. Transitions have been reported to be an index of activity-exploration because of habituation over time, and the time spent in each compartment to be a reflection of aversion. Classic anxiolytics (benzodiazepines) as well as the newer anxiolytic-like compounds (e.g. serotonergic drugs or drugs acting on neuropeptide receptors) can be detected using this paradigm. It has the advantages of being quick and easy to use, without requiring the prior training of animals. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:55 / 65
页数:11
相关论文
共 106 条
  • [1] The role of corticotropin-releasing factor in depression and anxiety disorders
    Arborelius, L
    Owens, MJ
    Plotsky, PM
    Nemeroff, CB
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) : 1 - 12
  • [2] PROFILES OF INTERACTION OF R(+)/S(-)-ZACOPRIDE AND ANXIOLYTIC AGENTS IN A MOUSE MODEL
    BARNES, NM
    CHENG, CHK
    COSTALL, B
    GE, J
    KELLY, ME
    NAYLOR, RJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 218 (01) : 91 - 100
  • [3] THE INTERACTION OF R(+)-AND S(-)-ZACOPRIDE WITH PCPA TO MODIFY RODENT AVERSIVE BEHAVIOR
    BARNES, NM
    COSTALL, B
    GE, J
    KELLY, ME
    NAYLOR, RJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 218 (01) : 15 - 25
  • [4] KETOTIFEN AND ITS ANALOGS REDUCE AVERSIVE RESPONDING IN THE RODENT
    BARNES, NM
    COSTALL, B
    KELLY, ME
    ONAIVI, ES
    NAYLOR, RJ
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (04) : 785 - 793
  • [5] 5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS
    BARRETT, JE
    VANOVER, KE
    [J]. PSYCHOPHARMACOLOGY, 1993, 112 (01) : 1 - 12
  • [6] BARRY J M, 1987, British Journal of Pharmacology, V92, p651P
  • [7] ANXIOGENIC EFFECTS OF METHYL-BETA-CARBOLINE-3-CARBOXYLATE IN A LIGHT DARK CHOICE SITUATION
    BELZUNG, C
    MISSLIN, R
    VOGEL, E
    DODD, RH
    CHAPOUTHIER, G
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 28 (01) : 29 - 33
  • [8] COMPARISON OF DIFFERENT BEHAVIORAL-TEST SITUATIONS USED IN PSYCHOPHARMACOLOGY FOR MEASUREMENT OF ANXIETY
    BELZUNG, C
    LEPAPE, G
    [J]. PHYSIOLOGY & BEHAVIOR, 1994, 56 (03) : 623 - 628
  • [9] BEHAVIORAL-EFFECTS OF THE BENZODIAZEPINE RECEPTOR PARTIAL AGONIST RO-16-6028 IN MICE
    BELZUNG, C
    MISSLIN, R
    VOGEL, E
    [J]. PSYCHOPHARMACOLOGY, 1989, 97 (03) : 388 - 391
  • [10] PD135158, A CCK-B ANTAGONIST, REDUCES STATE, BUT NOT TRAIT ANXIETY IN MICE
    BELZUNG, C
    PINEAU, N
    BEUZEN, A
    MISSLIN, R
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (02) : 433 - 436